The Fallout of the USAID Funding Freeze: Implications for Global Health and Biopharmaceutical Innovation

The recent executive order issued by the Trump administration freezing all new and existing USAID funding has sent shockwaves through the global health and biopharmaceutical landscape. This abrupt halt, effective January 20, 2025, and initially framed as a 90-day review of foreign aid programs, has resulted in the immediate suspension of dozens of vital clinicalRead More